SCHEMBL282938

SCHEMBL282938

CCCCCCCCCC(=O)Nc1ccccc1

nearest known ligand 0.96

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SOAT2 O75908 1/20 0.82
SOAT1 P35610 1/20 0.82
HDAC1 Q13547 11/20 0.72
HDAC3 O15379 11/20 0.72
HDAC2 Q92769 10/20 0.72
ICMT O60725 1/20 0.72
ALB P02768 1/20 0.72
HDAC8 Q9BY41 13/20 0.72
HDAC6 Q9UBN7 11/20 0.72
HDAC4 P56524 9/20 0.72
HDAC7 Q8WUI4 9/20 0.72
HDAC11 Q96DB2 9/20 0.72
HDAC9 Q9UKV0 9/20 0.72
HDAC5 Q9UQL6 9/20 0.72
HDAC10 Q969S8 8/20 0.72
KDM4E B2RXH2 1/20 0.72
BRD4 O60885 1/20 0.72
NCOR1 O75376 1/20 0.72
NR1I2 O75469 1/20 0.72
EGFR P00533 1/20 0.72

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8743007 1.00 SOAT2 (0.82) SOAT2SOAT1HDAC1HDAC3HDAC2
SCHEMBL8743085 1.00 SOAT2 (0.82) SOAT2SOAT1HDAC1HDAC3HDAC2
SCHEMBL9388173 1.00 SOAT2 (0.82) SOAT2SOAT1HDAC1HDAC3HDAC2
SCHEMBL2138777 1.00 SOAT2 (0.82) SOAT2SOAT1HDAC1HDAC3HDAC2
SCHEMBL8743011 1.00 SOAT2 (0.82) SOAT2SOAT1HDAC1HDAC3HDAC2
SCHEMBL8743155 1.00 SOAT2 (0.82) SOAT2SOAT1HDAC1HDAC3HDAC2
SCHEMBL541399 1.00 SOAT2 (0.82) SOAT2SOAT1HDAC1HDAC3HDAC2
SCHEMBL8742971 1.00 SOAT2 (0.82) SOAT2SOAT1HDAC1HDAC3HDAC2
SCHEMBL8743258 1.00 SOAT2 (0.82) SOAT2SOAT1HDAC1HDAC3HDAC2
Hexadecanoic Acid Phenylamide SCHEMBL4138725 1.00 SOAT2 (0.82) SOAT2SOAT1HDAC1HDAC3HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119351791-A Method for deeply removing antimony and tantalum from niobium-containing solution 郑州大学 2025-01-24 CN claimed
US-20260062580-A1 REVERSIBLY THERMOCHROMIC COMPOSITION, REVERSIBLY THERMOCHROMIC MICROCAPSULE PIGMENT ENCAPSULATING REVERSIBLY THERMOCHROMIC COMPOSITION, AND WRITING INSTRUMENT USING REVERSIBLY THERMOCHROMIC MICROCAPSULE PIGMENT THE PILOT INK CO., LTD. (JP) 2026-03-05 US disclosed
US-12460099-B2 Reversibly thermochromic composition, reversibly thermochromic microcapsule pigment encapsulating reversibly thermochromic composition, and writing instrument using reversibly thermochromic microcapsule pigment THE PILOT INK CO., LTD. (JP) 2025-11-04 US disclosed
EP-3608386-B1 REVERSIBLY THERMOCHROMIC COMPOSITION, AND REVERSIBLY THERMOCHROMIC MICROCAPSULE PIGMENT HAVING SAME ENCLOSED THEREIN PILOT INK CO LTD (JP) 2025-02-19 EP disclosed
CN-119351791-A Method for deeply removing antimony and tantalum from niobium-containing solution 郑州大学 2025-01-24 CN disclosed
US-12123107-B2 Reversibly thermochromic composite fiber KABUSHIKI KAISHA PILOT CORPORATION (JP) 2024-10-22 US disclosed
CN-114585620-B Oxadiazole compounds or salts thereof, agrohorticultural fungicides containing the same, and methods of use thereof 日本农药株式会社 2024-02-23 CN disclosed
CN-111960962-B Nickel-catalyzed alpha-alkylation method of acetamide and thioacetamide 山东师范大学 2023-03-07 CN disclosed
US-20230018132-A1 REVERSIBLY THERMOCHROMIC AQUEOUS INKJET PRINTER INK COMPOSITION, INKJET PRINTER AND INK CARTRIDGE USING THE SAME RISO TECHNOLOGIES CORPORATION (JP) 2023-01-19 US disclosed
US-20220169919-A1 REVERSIBLY THERMOCHROMIC COMPOSITION, REVERSIBLY THERMOCHROMIC MICROCAPSULE PIGMENT ENCAPSULATING REVERSIBLY THERMOCHROMIC COMPOSITION, AND WRITING INSTRUMENT USING REVERSIBLY THERMOCHROMIC MICROCAPSULE PIGMENT THE PILOT INK CO., LTD. (JP) 2022-06-02 US disclosed
WO-2011032169-A2 PHARMACEUTICAL COMPOSITIONS AND FORMULATIONS INCLUDING INHIBITORS OF THE PLECKSTRIN HOMOLOGY DOMAIN AND METHODS FOR USING SAME PHUSIS THERAPEUTICS INC. (US) 2011-03-17 WO disclosed
EP-2291349-A2 SMALL MOLECULE INHIBITORS OF THE PLECKSTRIN HOMOLOGY DOMAIN AND METHODS FOR USING SAME The Board of Regents of The University of Texas System (US) 2011-03-09 EP disclosed
WO-2009129267-A2 SMALL MOLECULE INHIBITORS OF THE PLECKSTRIN HOMOLOGY DOMAIN AND METHODS FOR USING SAME THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 2009-10-22 WO disclosed
US-20090131657-A1 PROCESS FOR ALKENYLATING CARBOXAMIDES BASF SE (DE) 2009-05-21 US disclosed
EP-0950669-B1 Method of catalytic crosslinking of polymers and two-pack composition used therein ROHM & HAAS (US) 2004-09-08 EP disclosed
US-6306991-B1 TWO PART COATING COMPOSITION WITH TWO CONTAINERS, OXIDATIVE POLYMERS WITH CROSSLINKABLE FUNCTIONAL GROUPS ROHM AND HAAS COMPANY 2001-10-23 US disclosed
US-6149977-A CONTACTING THE OXIDATIVE POLYMER WITH A CATALYTIC AMOUNT OF AN OXIDIZING ENZYME, SUCH AS HORSERADISH PEROXIDASE. ROHM AND HAAS COMPANY (US) 2000-11-21 US disclosed
EP-0950669-A2 Method of catalytic crosslinking of polymers and two-pack composition used therein ROHM AND HAAS COMPANY (US) 1999-10-20 EP disclosed
CN-1046166-A Contain the preparation method that the new 19-of 11 β-carbonated chain removes the first steroidal compounds ROUSSEL UCLAF (FR) 1990-10-17 CN disclosed
US-4835312-A Production process of N-substituted amide compounds MITSUI CHEMICALS, INCORPORATED (JP) 1989-05-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260062580-A1 REVERSIBLY THERMOCHROMIC COMPOSITION, REVERSIBLY THERMOCHROMIC MICROCAPSULE PIGMENT ENCAPSULATING REVERSIBLY THERMOCHROMIC COMPOSITION, AND WRITING INSTRUMENT USING REVERSIBLY THERMOCHROMIC MICROCAPSULE PIGMENT TYR, SCO2, HBB SOAT2 2022/4885SOAT1 2226/4885HDAC1 4615/4885
US-20090131657-A1 PROCESS FOR ALKENYLATING CARBOXAMIDES PRMT5, CYC1, CBR3 SOAT2 3434/4885SOAT1 3570/4885HDAC1 47/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.